These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7728131

  • 1. Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials.
    Schuening FG, Nemunaitis J, Appelbaum FR, Storb R.
    Bone Marrow Transplant; 1994; 14 Suppl 4():S74-7. PubMed ID: 7728131
    [Abstract] [Full Text] [Related]

  • 2. Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
    Schuening FG, von Kalle C, Kiem HP, Appelbaum FR, Deeg HJ, Pepe M, Gooley T, Graham TC, Hackman RC, Storb R.
    Exp Hematol; 1997 Nov; 25(12):1240-5. PubMed ID: 9357967
    [Abstract] [Full Text] [Related]

  • 3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 4. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
    Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ.
    Bone Marrow Transplant; 1995 Jun; 15(6):949-54. PubMed ID: 7581096
    [Abstract] [Full Text] [Related]

  • 5. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL.
    Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
    [Abstract] [Full Text] [Related]

  • 6. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 7. DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.
    Storb R, Raff RF, Appelbaum FR, Deeg HJ, Graham TC, Schuening FG, Shulman H, Yu C, Bryant E, Burnett R.
    Blood; 1994 Nov 15; 84(10):3558-66. PubMed ID: 7524741
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
    Schuening FG, Storb R, Goehle S, Graham TC, Hackman R, Mori M, Souza LM, Appelbaum FR.
    Blood; 1990 Aug 01; 76(3):636-40. PubMed ID: 1696148
    [Abstract] [Full Text] [Related]

  • 9. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A.
    Exp Hematol; 1995 Dec 01; 23(14):1503-8. PubMed ID: 8542938
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan 01; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 01; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 14. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
    Yu C, Storb R, Deeg HJ, Graham TC, Scheuning FG, Huss R, Seidel K, Fitzsimmons WE.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):649-53. PubMed ID: 8722370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Apr 01; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 17. A Canine Model of Chronic Graft-versus-Host Disease.
    Graves SS, Rezvani A, Sale G, Stone D, Parker M, Rosinski S, Spector M, Swearingen B, Kean L, Storb R.
    Biol Blood Marrow Transplant; 2017 Mar 01; 23(3):420-427. PubMed ID: 28013013
    [Abstract] [Full Text] [Related]

  • 18. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J, Terol MJ, Urbano-Ispizua A, Rovira M, Marin P, Carreras E, Batlle M, Rozman C.
    Exp Hematol; 1994 Jul 01; 22(7):566-72. PubMed ID: 8013572
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 01; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.